IDNNA

IDNNA
Names
Preferred IUPAC name
1-(4-Iodo-2,5-dimethoxyphenyl)-N,N-dimethylpropan-2-amine
Other names
2,5-Dimethoxy-4-iodo-N,N-dimethylamphetamine
2,5-Dimethoxy-4-iodo-1-ethyl-(α-methyl)amine
Identifiers
CAS Number
3D model (JSmol)
ChEMBL
ChemSpider
PubChem CID
UNII
InChI
  • InChI=1S/C13H20INO2/c1-9(15(2)3)6-10-7-13(17-5)11(14)8-12(10)16-4/h7-9H,6H2,1-5H3 checkY
    Key: XBCUSBRGRALQID-UHFFFAOYSA-N checkY
  • InChI=1/C13H20INO2/c1-9(15(2)3)6-10-7-13(17-5)11(14)8-12(10)16-4/h7-9H,6H2,1-5H3
    Key: XBCUSBRGRALQID-UHFFFAOYAY
SMILES
  • Ic1cc(OC)c(cc1OC)CC(N(C)C)C
Properties
Chemical formula
C13H20NO2I
Molar mass 349.211 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)
Infobox references

IDNNA (2,5-dimethoxy-4-iodo-N,N-dimethylamphetamine) is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N,N-dimethyl analog of DOI. IDNNA was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 2.6 mg, and the duration unknown.[1] IDNNA produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of IDNNA.

Legality

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]

See also

References

  1. IDNNA Entry in PiHKAL
  2. "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.


This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.